Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Hisamitsu Pharm Co Drug Patent Portfolio

Hisamitsu Pharm Co owns 1 orange book drug protected by 2 US patents Given below is the list of Hisamitsu Pharm Co's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8809615 Adhesive preparation 03 Jan, 2030
Active
US9233184 Adhesive preparation 01 Aug, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Hisamitsu Pharm Co.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 02 Feb, 2022 US8809615
Payment of Maintenance Fee, 4th Year, Large Entity 08 Feb, 2018 US8809615
Email Notification
Critical
05 Oct, 2016 US8809615
Mail-Petition Decision - Denied 30 Sep, 2016 US8809615
Petition Decision - Denied 29 Sep, 2016 US8809615
Post Issue Communication - Certificate of Correction 01 Oct, 2014 US8809615
Petition Entered 04 Sep, 2014 US8809615
Recordation of Patent Grant Mailed
Critical
19 Aug, 2014 US8809615
Patent Issue Date Used in PTA Calculation
Critical
19 Aug, 2014 US8809615
Email Notification
Critical
01 Aug, 2014 US8809615
Email Notification
Critical
31 Jul, 2014 US8809615
Issue Notification Mailed
Critical
30 Jul, 2014 US8809615
Mail-Petition Decision - Granted 28 Jul, 2014 US8809615
Petition Decision - Granted
Critical
25 Jul, 2014 US8809615
Application Is Considered Ready for Issue
Critical
09 Jul, 2014 US8809615


Hisamitsu Pharm Co's Family Patents

Hisamitsu Pharm Co drugs have patent protection in a total of 16 countries. It's US patent count contributes only to 19.0% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Hisamitsu Pharm Co Drug List

Given below is the complete list of Hisamitsu Pharm Co's drugs and the patents protecting them.


1. Salonpas

Salonpas is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8809615 Adhesive preparation 03 Jan, 2030
(5 years from now)
Active
US9233184 Adhesive preparation 01 Aug, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Salonpas's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List